by John Mordecai
November 18, 2018
Cost-effectiveness of Extended-release Injectable Naltrexone among Incarcerated Persons with Opioid Use Disorder Before Release from Prison Versus After ReleaseAugust 01, 2022
Intern Spotlight: Grace L. Edwards, Jessica Girard, Lyric Harris, and Antara SahaJuly 25, 2022
Five Researchers Receive CHERISH Pilot Awards to Advance the Treatment of Substance Use Disorders, HCV, and HIVJuly 17, 2022
Evidence for Supportive Prenatal Substance Use PoliciesJune 29, 2022
CHERISH Returns to Conferences in PersonMay 09, 2022